.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Cerilliant
Daiichi Sankyo
Accenture
Harvard Business School
AstraZeneca
Medtronic
US Army
UBS
Merck

Generated: June 24, 2017

DrugPatentWatch Database Preview

Methacycline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for methacycline hydrochloride and what is the scope of methacycline hydrochloride patent protection?

Methacycline hydrochloride
is the generic ingredient in one branded drug marketed by Medpointe Pharm Hlc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for methacycline hydrochloride.

Summary for Generic Name: methacycline hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list6
Bulk Api Vendors: see list35
Clinical Trials: see list2,244
Patent Applications: see list960
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methacycline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc
RONDOMYCIN
methacycline hydrochloride
SYRUP;ORAL060641-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Medpointe Pharm Hlc
RONDOMYCIN
methacycline hydrochloride
CAPSULE;ORAL060641-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Medpointe Pharm Hlc
RONDOMYCIN
methacycline hydrochloride
CAPSULE;ORAL060641-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cipla
McKinsey
Citi
US Army
UBS
Baxter
Medtronic
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot